State-of-the-Art Cardiovascular Medicine in Europe 2022
Submission Deadline: 15 Sep 2022
Guest Editors
Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy
Interests: Hypertension; Chronic Heart Failure; Hypertension
Filippos Triposkiadis MD, PhD, FESC, FACC, FHFA
School of Medicine, European University Cyprus, Nicosia, Cyprus;Department of Cardiology, University Hospital of Larissa, Larissa, Greece
Interests: Chronic heart failure; Diseases of the aorta; Coronary artery disease chronic; Myocardial disease
GRN Hospital Weinheim, Cardiology and Vascular Medicine, Weinheim, Germany
Interests: atherosclerosis; imaging; cardiology; inflammation; interventional cardiology; heart failure; computed tomography; magnetic resonance; myocardial infarction; echocardiography
Special Issue in IMR Press journals
Special Issue in Applications of Coronary Computed Tomography Angiography (CCTA)
Department of Medical Biotechnologies, Division of Cardiology, University of Siena, Siena, Italy
Interests: Echocardiography; Chronic Heart Failure
Special Issue Information
Dear Colleagues,
Cardiovascular disease (CVD) remains the leading cause of death around the world. According to the European Cardiovascular Disease Statistics 2017, CVD caused 3.9 million deaths in Europe each year, which are more than half of all deaths across the European Region. This Special Issue aims to provide a comprehensive overview of state-of-the-art of Cardiovascular Medicine in Europe. We invite research papers that will consolidate our understanding in this area.
In this Special Issue, we will focus and will be interested in , but are not limited to, receiving manuscript contributions in one or more of the following areas:
• Management of Heart Failure
• Diseases of the aorta
• Myocardial disease
• Cardiovascular imaging (cardiac CT; cardiac MRI)
• Interventional cardiology
• Peripheral vascular interventions
• Heart transplantation
• Valvular heart disease
• Echocardiography
• Electrocardiogram
• Cardiovascular Prevention
• Arterial Hypertension
• Arrhythmias (Sudden cardiac death)
It is my pleasure to invite you to submit manuscripts on the subject “State-of-the-Art Cardiovascular Medicine in Europe 2022” for this Special Issue. Full papers and communications, as well as comprehensive reviews, are welcome. Please feel free to contact me, the guest editor, in case of further questions.
Prof. Massimo Volpe, Prof. Filippos Triposkiadis, Prof. Grigorios Korosoglou and Prof. Matteo Cameli
Guest Editors
Keywords
- Sudden cardiac death
- Arrhythmias
- Arterial Hypertension
- Cardiovascular disease
- Prevention
- Cardiac CT
- Cardiac MRI
- Interventional cardiology
- Vascular intervention
- Electrocardiogram
- Heart failure
Manuscript Submission Information
Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted manuscripts should be well formatted in good English.
Published Papers (12)
Updates on Post-Resuscitation Care. After the Return of Spontaneous Circulation beyond the 2021 Guidelines
Rev. Cardiovasc. Med. 2022, 23(11), 373; https://doi.org/10.31083/j.rcm2311373
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Europe 2022)
Recurrent Spontaneous Coronary Artery Dissection: Association with Takotsubo Syndrome and Fibromuscular Dysplasia; Comprehensive Review
Rev. Cardiovasc. Med. 2022, 23(11), 367; https://doi.org/10.31083/j.rcm2311367
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Europe 2022)
Sacubitril/valsartan in Heart Failure and Beyond—From Molecular Mechanisms to Clinical Relevance
Rev. Cardiovasc. Med. 2022, 23(7), 238; https://doi.org/10.31083/j.rcm2307238
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Europe 2022)
Role of Echocardiography in the Management of Patients with Advanced (Stage D) Heart Failure Related to Nonischemic Cardiomyopathy
Rev. Cardiovasc. Med. 2022, 23(6), 214; https://doi.org/10.31083/j.rcm2306214
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Europe 2022)
Drug-coated Balloons in the Neurovascular Setting: A Comprehensive, Systematic Review of Current Use and Indications
Rev. Cardiovasc. Med. 2022, 23(4), 128; https://doi.org/10.31083/j.rcm2304128
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Europe 2022)
Cardiorenal Impact of SGLT-2 Inhibitors: A Conceptual Revolution in The Management of Type 2 Diabetes, Heart Failure and Chronic Kidney Disease
Rev. Cardiovasc. Med. 2022, 23(3), 106; https://doi.org/10.31083/j.rcm2303106
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Europe 2022)
Treatment of myocardial ischaemia-reperfusion injury in patients with ST-segment elevation myocardial infarction: promise, disappointment, and hope
Rev. Cardiovasc. Med. 2022, 23(1), 23; https://doi.org/10.31083/j.rcm2301023
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Europe 2022)
Disparities between guideline statements on acute and post-acute management of cervical artery dissection
Rev. Cardiovasc. Med. 2022, 23(1), 9; https://doi.org/10.31083/j.rcm2301009
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Europe 2022)
Cardiovascular outcomes of glucose lowering therapy in chronic kidney disease patients: a systematic review with meta-analysis
Rev. Cardiovasc. Med. 2021, 22(4), 1479–1490; https://doi.org/10.31083/j.rcm2204152
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Europe 2022)
Amiodarone in ventricular arrhythmias: still a valuable resource?
Rev. Cardiovasc. Med. 2021, 22(4), 1383–1392; https://doi.org/10.31083/j.rcm2204143
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Europe 2022)
Determinants of exercise adherence and maintenance among patients with hypertension: a narrative review
Rev. Cardiovasc. Med. 2021, 22(4), 1271–1278; https://doi.org/10.31083/j.rcm2204134
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Europe 2022)
Right ventricular myocardial infarction: pathophysiology, clinical implications and management
Rev. Cardiovasc. Med. 2021, 22(4), 1229–1240; https://doi.org/10.31083/j.rcm2204131
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Europe 2022)